Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein

Yanlin Wang, Amy Hacker, Tracy Murray Stewart, Jennifer G. Fleischer, Patrick M. Woster, Robert A Casero

Research output: Contribution to journalArticle

Abstract

The oxidation of polyamines induced by antitumour polyamine analogues has been associated with tumour response to specific agents. The human spermine oxidase, SMO(PAOh1), is one enzyme that may play a direct role in the cellular response to the antitumour polyamine analogues. In the present study, the induction of SMO(PAOh1) enzyme activity by CPENSpm [N1-ethyl-N 11-(cyclopropyl)methyl-4,8,diazaundecane] is demonstrated to be a result of newly synthesized mRNA and protein. Inhibition of new RNA synthesis by actinomycin D inhibits both the appearance of SMO(PAOh1) mRNA and enzyme activity. Similarly, inhibition of newly synthesized protein with cycloheximide prevents analogue-induced enzyme activity. Half-life determinations indicate that stabilization of SMO(PAOh1) protein does not play a significant role in analogue-induced activity. However, half-life experiments using actinomycin D indicate that CPENSpm treatment not only increases mRNA expression, but also leads to a significant increase in mRNA half-life (17.1 and 8.8 h for CPENSpm-treated cells and control respectively). Using reporter constructs encompassing the SMO(PAOh1) promoter region, a 30-90% increase in transcription is observed after exposure to CPENSpm. The present results are consistent with the hypothesis that analogue-induced expression of SMO(PAOh1) is a result of increased transcription and stabilization of SMO(PAOh1) mRNA, leading to increased protein production and enzyme activity. These data indicate that the major level of control of SMO(PAOh1) expression in response to polyamine analogues exposure is at the level of mRNA.

Original languageEnglish (US)
Pages (from-to)543-547
Number of pages5
JournalBiochemical Journal
Volume386
Issue number3
DOIs
StatePublished - Mar 15 2005

Fingerprint

Stabilization
Polyamines
Enzyme activity
Messenger RNA
Half-Life
Enzymes
Proteins
Dactinomycin
Transcription
Enzyme inhibition
Cycloheximide
Genetic Promoter Regions
polyamine oxidase
Tumors
Cells
RNA
Oxidation
N(1)-ethyl-N-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine
Neoplasms
Experiments

Keywords

  • Hydrogen peroxide (H O)
  • N-acetylpolyamine oxidase (PAO)
  • Polyamine
  • Reactive oxygen species
  • Spermidine/spermine N-acetyltransferase (SSAT)
  • Spermine oxidase [SMO(PAOh1)]

ASJC Scopus subject areas

  • Biochemistry

Cite this

Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein. / Wang, Yanlin; Hacker, Amy; Murray Stewart, Tracy; Fleischer, Jennifer G.; Woster, Patrick M.; Casero, Robert A.

In: Biochemical Journal, Vol. 386, No. 3, 15.03.2005, p. 543-547.

Research output: Contribution to journalArticle

@article{8ca3de983a574f08be5c337f9d09490c,
title = "Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein",
abstract = "The oxidation of polyamines induced by antitumour polyamine analogues has been associated with tumour response to specific agents. The human spermine oxidase, SMO(PAOh1), is one enzyme that may play a direct role in the cellular response to the antitumour polyamine analogues. In the present study, the induction of SMO(PAOh1) enzyme activity by CPENSpm [N1-ethyl-N 11-(cyclopropyl)methyl-4,8,diazaundecane] is demonstrated to be a result of newly synthesized mRNA and protein. Inhibition of new RNA synthesis by actinomycin D inhibits both the appearance of SMO(PAOh1) mRNA and enzyme activity. Similarly, inhibition of newly synthesized protein with cycloheximide prevents analogue-induced enzyme activity. Half-life determinations indicate that stabilization of SMO(PAOh1) protein does not play a significant role in analogue-induced activity. However, half-life experiments using actinomycin D indicate that CPENSpm treatment not only increases mRNA expression, but also leads to a significant increase in mRNA half-life (17.1 and 8.8 h for CPENSpm-treated cells and control respectively). Using reporter constructs encompassing the SMO(PAOh1) promoter region, a 30-90{\%} increase in transcription is observed after exposure to CPENSpm. The present results are consistent with the hypothesis that analogue-induced expression of SMO(PAOh1) is a result of increased transcription and stabilization of SMO(PAOh1) mRNA, leading to increased protein production and enzyme activity. These data indicate that the major level of control of SMO(PAOh1) expression in response to polyamine analogues exposure is at the level of mRNA.",
keywords = "Hydrogen peroxide (H O), N-acetylpolyamine oxidase (PAO), Polyamine, Reactive oxygen species, Spermidine/spermine N-acetyltransferase (SSAT), Spermine oxidase [SMO(PAOh1)]",
author = "Yanlin Wang and Amy Hacker and {Murray Stewart}, Tracy and Fleischer, {Jennifer G.} and Woster, {Patrick M.} and Casero, {Robert A}",
year = "2005",
month = "3",
day = "15",
doi = "10.1042/BJ20041084",
language = "English (US)",
volume = "386",
pages = "543--547",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Induction of human spermine oxidase SMO(PAOh1) is regulated at the levels of new mRNA synthesis, mRNA stabilization and newly synthesized protein

AU - Wang, Yanlin

AU - Hacker, Amy

AU - Murray Stewart, Tracy

AU - Fleischer, Jennifer G.

AU - Woster, Patrick M.

AU - Casero, Robert A

PY - 2005/3/15

Y1 - 2005/3/15

N2 - The oxidation of polyamines induced by antitumour polyamine analogues has been associated with tumour response to specific agents. The human spermine oxidase, SMO(PAOh1), is one enzyme that may play a direct role in the cellular response to the antitumour polyamine analogues. In the present study, the induction of SMO(PAOh1) enzyme activity by CPENSpm [N1-ethyl-N 11-(cyclopropyl)methyl-4,8,diazaundecane] is demonstrated to be a result of newly synthesized mRNA and protein. Inhibition of new RNA synthesis by actinomycin D inhibits both the appearance of SMO(PAOh1) mRNA and enzyme activity. Similarly, inhibition of newly synthesized protein with cycloheximide prevents analogue-induced enzyme activity. Half-life determinations indicate that stabilization of SMO(PAOh1) protein does not play a significant role in analogue-induced activity. However, half-life experiments using actinomycin D indicate that CPENSpm treatment not only increases mRNA expression, but also leads to a significant increase in mRNA half-life (17.1 and 8.8 h for CPENSpm-treated cells and control respectively). Using reporter constructs encompassing the SMO(PAOh1) promoter region, a 30-90% increase in transcription is observed after exposure to CPENSpm. The present results are consistent with the hypothesis that analogue-induced expression of SMO(PAOh1) is a result of increased transcription and stabilization of SMO(PAOh1) mRNA, leading to increased protein production and enzyme activity. These data indicate that the major level of control of SMO(PAOh1) expression in response to polyamine analogues exposure is at the level of mRNA.

AB - The oxidation of polyamines induced by antitumour polyamine analogues has been associated with tumour response to specific agents. The human spermine oxidase, SMO(PAOh1), is one enzyme that may play a direct role in the cellular response to the antitumour polyamine analogues. In the present study, the induction of SMO(PAOh1) enzyme activity by CPENSpm [N1-ethyl-N 11-(cyclopropyl)methyl-4,8,diazaundecane] is demonstrated to be a result of newly synthesized mRNA and protein. Inhibition of new RNA synthesis by actinomycin D inhibits both the appearance of SMO(PAOh1) mRNA and enzyme activity. Similarly, inhibition of newly synthesized protein with cycloheximide prevents analogue-induced enzyme activity. Half-life determinations indicate that stabilization of SMO(PAOh1) protein does not play a significant role in analogue-induced activity. However, half-life experiments using actinomycin D indicate that CPENSpm treatment not only increases mRNA expression, but also leads to a significant increase in mRNA half-life (17.1 and 8.8 h for CPENSpm-treated cells and control respectively). Using reporter constructs encompassing the SMO(PAOh1) promoter region, a 30-90% increase in transcription is observed after exposure to CPENSpm. The present results are consistent with the hypothesis that analogue-induced expression of SMO(PAOh1) is a result of increased transcription and stabilization of SMO(PAOh1) mRNA, leading to increased protein production and enzyme activity. These data indicate that the major level of control of SMO(PAOh1) expression in response to polyamine analogues exposure is at the level of mRNA.

KW - Hydrogen peroxide (H O)

KW - N-acetylpolyamine oxidase (PAO)

KW - Polyamine

KW - Reactive oxygen species

KW - Spermidine/spermine N-acetyltransferase (SSAT)

KW - Spermine oxidase [SMO(PAOh1)]

UR - http://www.scopus.com/inward/record.url?scp=15944398306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944398306&partnerID=8YFLogxK

U2 - 10.1042/BJ20041084

DO - 10.1042/BJ20041084

M3 - Article

C2 - 15496143

AN - SCOPUS:15944398306

VL - 386

SP - 543

EP - 547

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -